NEW DELHI / BENGALURU: India is accelerating its review of coronavirus vaccines developed by Pfizer Inc and AstraZeneca for emergency use, a senior government official said on Monday, as the world’s second-worst affected country struggles to contain the outbreak. The Indian government is pinning its hopes of mass supply of …
Read More »Coronavirus Vaccine Update: As Pfizer and Covishield seek approvals in India, how soon can we expect a vaccine?
Serum Institute of India, Pune became the second company after Pfizer to apply for an emergency use authorization for its trial vaccine, the Oxford COVID-19 vaccine (called COVISHIELD) in the country. The vaccine is currently undergoing phase III testing in India and other parts of the world. The news, which …
Read More »Why the Pfizer Emergency Use App Decision Isn’t Easy
From insisting on seeking legal protection to waiving clinical trials, Pfizer’s application to the Comptroller General of Drugs of India (DCGI), seeking permission for the Emergency Use Authorization of its COVID-19 vaccine, it has too many buts and yes. The committee of subject matter experts constituted by DCGI is expected …
Read More »Indian Coronavirus Vaccine: India Puts Hopes on 4 Covid-19 Vaccines to Inoculate Rs 30 Crore in July | India News
NEW DELHI: The government expects two Covid-19 vaccines, Covishield from Oxford-AstraZeneca and Covaxin from Bharat Biotech, to be available in January and about four vaccines by the end of April, increasing prospects for adequate supplies to inoculate a priority of Rs 30 crore. population in July, an official said. While …
Read More »32,981 recent COVID-19 cases in India
Coronavirus Cases in India: The recovery rate is 94.45 percent. New Delhi: India recorded 32,981 new COVID-19 cases in the past 24 hours, bringing the total number of active coronavirus cases in the country to 3,96,729, the Union Ministry of Health and Family Welfare said on Monday. With 39,109 new …
Read More »Indian Coronavirus Vaccine: India Puts Hopes on 4 Covid-19 Vaccines to Inoculate Rs 30 Crore in July | India News
NEW DELHI: The government expects two Covid-19 vaccines, Covishield from Oxford-AstraZeneca and Covaxin from Bharat Biotech, to be available in January and about four vaccines by the end of April, increasing prospects for adequate supplies to inoculate a priority of Rs 30 crore. population in July, an official said. While …
Read More »Explained: Why Three Former US Presidents Offer To Publicly Take The Covid-19 Vaccine
Written by Rahel Philipose | New Delhi | Updated: December 6, 2020 7:18:50 pm The three most recent former US presidents, Barack Obama, George W Bush and Bill Clinton, have all volunteered to receive their Covid-19 vaccines in front of the camera. (AP) Three former presidents of the United States …
Read More »Pfizer seeks emergency use authorization for its COVID-19 vaccine in India
The firm, in its request submitted to the drug regulator, has requested permission to import the vaccine for sale and distribution in the country. Pfizer India has become the first pharmaceutical company to apply to the Controller General of Drugs of India (DCGI) for an emergency use authorization for its …
Read More »The race to vaccinate the world against covid-19 intensifies
The result is a fragmentary global vaccination campaign that is likely to unfold at very different rates. For most people around the world, a vaccine will remain a distant hope for several months, and it could be years before the poorest countries cover their populations. Consequently, governments may need to …
Read More »Health Ministry’s claim that Haryana Minister Anil Vij received a dose of covaxin raises questions about the ethics of the trial
Haryana Health Minister Anil Vij who participated in the phase III trials of Bharat Biotech coronavirus Covaxin vaccine, has tested positive for COVID-19. “They tested positive for Corona. I am admitted to the Ambala Cantt Civil Hospital. All those who have been in close contact with me are advised to …
Read More »